Technical Analysis for ALBT - Avalon GloboCare Corp.

Grade Last Price % Change Price Change
C 0.46 -1.25% -0.01
ALBT closed down 1.25 percent on Monday, July 1, 2024, on 1 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Up

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Fell Below 200 DMA Bearish -1.25%
NR7 Range Contraction -1.25%
Narrow Range Bar Range Contraction -1.25%
Wide Bands Range Expansion -1.25%
Crossed Above 200 DMA Bullish -5.22%
Wide Bands Range Expansion -5.22%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 6 hours ago
10 DMA Support about 10 hours ago
Down 3% about 10 hours ago
Down 2 % about 10 hours ago
Fell Below Previous Day's Low about 10 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Avalon GloboCare Corp. is a clinical-stage, vertically integrated, leading CellTech bio-developer dedicated to advancing and empowering innovative, transformative immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics and therapeutics. Avalon also provides strategic advisory and outsourcing services to facilitate and enhance its clients' growth and development, as well as competitiveness in healthcare and CellTech industry markets. Through its subsidiary structure with unique integration of verticals from innovative R&D to automated bioproduction and accelerated clinical development, Avalon is establishing a leading role in the fields of cellular immunotherapy (including CAR-T/NK), exosome technology (ACTEX™), and regenerative therapeutics.
Classification

Sector: Healthcare
Industry: Medical Care
Keywords: Medicine Clinical Medicine Immunotherapy Cell Therapy Exosome Bioproduction Vesicles

Is ALBT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.69
52 Week Low 0.24
Average Volume 3,528,556
200-Day Moving Average 0.48
50-Day Moving Average 0.38
20-Day Moving Average 0.53
10-Day Moving Average 0.46
Average True Range 0.09
RSI (14) 50.98
ADX 40.06
+DI 32.54
-DI 16.24
Chandelier Exit (Long, 3 ATRs) 1.18
Chandelier Exit (Short, 3 ATRs) 0.54
Upper Bollinger Bands 0.91
Lower Bollinger Band 0.16
Percent B (%b) 0.41
BandWidth 140.15
MACD Line 0.02
MACD Signal Line 0.03
MACD Histogram -0.0084
Fundamentals Value
Market Cap 5.11 Million
Num Shares 11 Million
EPS -0.93
Price-to-Earnings (P/E) Ratio -0.50
Price-to-Sales 4.16
Price-to-Book 7.51
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.49
Resistance 3 (R3) 0.49 0.48 0.49
Resistance 2 (R2) 0.48 0.47 0.48 0.49
Resistance 1 (R1) 0.47 0.47 0.47 0.47 0.48
Pivot Point 0.46 0.46 0.46 0.46 0.46
Support 1 (S1) 0.45 0.46 0.45 0.46 0.45
Support 2 (S2) 0.44 0.45 0.45 0.44
Support 3 (S3) 0.44 0.44 0.44
Support 4 (S4) 0.44